Sartorius (FRA:SRT3) PT Set at €116.00 by HSBC

HSBC set a €116.00 ($134.88) price objective on Sartorius (FRA:SRT3) in a research note published on Tuesday, February 5th. The brokerage currently has a neutral rating on the stock.

A number of other research firms have also recently weighed in on SRT3. Warburg Research set a €141.00 ($163.95) target price on shares of Sartorius and gave the stock a buy rating in a research note on Tuesday, January 29th. Berenberg Bank set a €110.00 ($127.91) target price on shares of Sartorius and gave the stock a neutral rating in a research note on Tuesday, January 29th. Kepler Capital Markets set a €107.00 ($124.42) price target on shares of Sartorius and gave the stock a sell rating in a report on Tuesday, January 29th. UBS Group set a €142.00 ($165.12) price target on shares of Sartorius and gave the stock a buy rating in a report on Tuesday, January 29th. Finally, Commerzbank set a €101.00 ($117.44) price target on shares of Sartorius and gave the stock a sell rating in a report on Friday, October 19th. Four analysts have rated the stock with a sell rating and four have issued a hold rating to the company. Sartorius has an average rating of Hold and an average target price of €116.38 ($135.32).

FRA:SRT3 traded up €0.80 ($0.93) during mid-day trading on Tuesday, reaching €140.20 ($163.02). The stock had a trading volume of 51,483 shares. Sartorius has a 12 month low of €71.00 ($82.56) and a 12 month high of €124.70 ($145.00).

About Sartorius

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors.

Featured Story: Insider Trading – What You Need to Know

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.